Sunnybrook
Michael Schull serves as the CEO and Senior Scientist at ICES since January 2000 and also holds the position of Senior Scientist at Sunnybrook Health Sciences Centre since January 2006. Additionally, Michael Schull has been a Board Member at Dignitas International since January 2004 and a Professor in the Division of Emergency Medicine at the University of Toronto since January 1998. Academic qualifications include a Doctor of Medicine (MD) from Queen's University, a Bachelor of Science (BSc) in Biochemistry from Queen's University, a Master's degree in Epidemiology and Biostatistics from McGill University, and a Harkness Fellowship in Health Care Policy and Practice from the Commonwealth Fund.
Sunnybrook
From our beginnings as a hospital for Canadian veterans, Sunnybrook has flourished into a fully affiliated teaching hospital of the University of Toronto, evolving to meet the needs of our growing community. Today, with 1.3 million patient visits each year, Sunnybrook has established itself across three campuses and is home to Canada's largest trauma centre. Sunnybrook's groundbreaking research changes the way patients are treated around the world. Our over 200 scientists and clinician-scientists conduct more than $100 million of breakthrough research each year. Tomorrow, we will discover ways to treat the untreatable. Our mission is to care for our patients and their families when it matters most. Our vision is to invent the future of health care. Our values are: excellence, collaboration, accountability, respect and engagement. See Sunnybrook's ambitious plan to invent the future of health care: sunnybrook.ca/strategicplan